Monday, April 16, 2012

Mesothelioma Still on the Rise in Japan

While the rate of mesothelioma continues to slowly decline in the U.S., the virulent asbestos-linked cancer is still on the rise in Japan.

A new Japanese study on future health trends projects that the incidence of mesothelioma won’t peak in Japan until 2027.  In the meantime, tens of thousands of Japanese workers are expected to die of mesothelioma.  Based on considerations such as the number of workers in industrial jobs and the likelihood of asbestos exposure, the study projects the mesothelioma death toll to reach 66,327 people ages 50 to 89 between 2003 and 2050.

Read more at Surviving Mesothelioma.

Sunday, April 15, 2012

Miracle Vaccine Universally Targets All Cancer Tumors

A research team, collaborating efforts between Tel Aviv University and a pharmaceutical company, Vaxil Bio Therapeutics, have discovered a powerful vaccine that could eliminate nearly 90% of all cancers. The vaccine – ImMucin – actually attacks a molecule that 90% of all cancers carry, jumpstarting the immune system. ImMucin is different than standard medications given to cancer patients, in that, it is a therapeutic vaccine rather a prophylactic vaccine. Prophylactic vaccines prevent cancers.

In the study, the research team administered ImMucin to 10 patients with a rare blood cancer known as multiple myeloma. 3 of the initial test patients reported that the cancer was completely eradicated, where the remaining 7 found their immune system boosted and better equipped to fight off the cancer.


Saturday, April 14, 2012

Large Study Shows Genetic Changes from Treatment May Be the Key to Personalized Care for Mesothelioma Patients

Researchers continue to focus projects on finding the key to offering physicians a reliable method for offering personalized treatment to their cancer patients.  While oncologists tend to rely on the combination chemotherapy treatment of pemetrexed and cisplatin for mesothelioma patients, researchers now believe that by “profiling genetic alterations in cancer with drug sensitivity” they may be able to identify an effective alternative for patients who do not respond to the treatment.


Friday, April 13, 2012

NORD Announces Celebration Focused on Raising Funds for Mesothelioma and Other Rare Diseases

The National Organization for Rare Disorders (NORD) has announced its Partners in Progress 2012 Celebration will be held at Union Station in Washington, DC, on Tuesday, May 15, 2012.  The event is NORD’s primary fundraising event for the year.  Patients with mesothelioma, an asbestos-related cancer and one of the 7,000 rare, or “orphan,” diseases or conditions affecting millions of Americans, are eligible for support through NORD’s programs.


Thursday, April 12, 2012

Mesothelioma Victims Center's Mesothelioma Victims Bill of Rights Now Names The Top Mesothelioma Attorneys For Any US Citizen Diagnosed With Mesothelioma - Quality Matters

The Mesothelioma Victims Center is the only group, or organization in the nation, that will provide individuals diagnosed with mesothelioma, or their family members with the names, and contact information for the best mesothelioma cancer treatment physicians, or medical practice groups, that have experience treating mesothelioma cancer victims in the specific area of the mesothelioma victim. Because the best mesothelioma attorneys get the best compensation for their clients, the Mesothelioma Victims Center will also provide a victim of mesothelioma, or their family members with the names, and contact information for the most successful mesothelioma attorneys, or mesothelioma trial attorneys in the nation. The group says, "No other group in the nation will provide an individual diagnosed with mesothelioma, or their loved ones with more free services, and quality matters. Our Mesothelioma Victims Bill of Rights is just one example, of how passionate we are about providing the absolute best service for a victim of mesothelioma, or their family members."

Read more at PR Web.

Wednesday, April 11, 2012

Mesothelioma Law Firm Helps Patients Understand Thoracic Surgery

Surgery is often the first line of defense against asbestos cancer. The California mesothelioma law firm of Clapper Patti Schweizer & Mason helps clients and those newly diagnosed to understand the role of thoracic surgery as treatment for mesothelioma. CPSM has been representing clients injured by asbestos and providing resources about mesothelioma, prevention and treatment to families and patients for more than 30 years.

Read more at San Francisco Chronicle.

Tuesday, April 10, 2012

Swedish and Italian Researchers Seek Funding for Development of Promising Mesothelioma Treatment

Developing a new, effective treatment for mesothelioma is not a project that is undertaken lightly.  The costs and effort that go into the work are tremendous for even the largest pharmaceutical companies.  But for smaller companies the costs can be prohibitive.  One Swedish company, however, is confident in its latest research and is actively seeking investors to help fund development of a novel therapy targeting both pleural and peritoneal mesothelioma.

Read more via